{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:31:29Z","timestamp":1787837489696,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cisplatin (Cis) is a chemotherapeutic agent used for several types of malignant tumors. Though, its use causes several adverse effects as ovarian toxicity through its effect on unbalancing antioxidant and oxidants causing oxidative stress and inflammation. The present study aimed to examine the potential protective effect of Empagliflozin (EMPA) on Cisplatin-induced ovarian damage. Forty-four adult female albino rats were divided into four groups: control group, EMPA group (EMPA 10\u00a0mg\/kg\/day, P.O) for 17\u00a0days, CIS group (CIS 7\u00a0mg\/kg, I.P) on day 14, Cis\u2009+\u2009EMPA group, EMPA (10\u00a0mg\/kg\/day, P.O) for 17\u00a0days with CIS (7\u00a0mg\/kg) on day 14. Oxidative stress markers, inflammatory markers and endoplasmic reticulum stress markers of ovarian tissues, and ovarian SIRTuin-1 (SIRT-1) were analyzed. Histopathological examination of ovaries and capase-9 immunohistochemical staining were also evaluated. CIS significantly increased ovarian oxidative stress markers, ER stress markers and reduced both AMH levels and SIRT-1 expression. Histopathological findings showed ovarian toxicity, necrosis and positive capase-9 immuno-expression. EMPA significantly decreased both oxidative stress and ER stress biomarkers with a significant improvement in the histopathological findings and a decrease in caspase-9 immuno-expression.<\/jats:p>\n                  <jats:p>Accordingly, EMPA protected against CIS-induced ovarian damage by activating both the SIRT-1\/NRF2 \/caspase-9 pathway and reducing ER stress.<\/jats:p>","DOI":"10.1007\/s10787-025-01970-0","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T17:46:43Z","timestamp":1759254403000},"page":"6887-6896","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The potential protective effect of Empagliflozin against Cisplatin-induced ovarian damage via upregulation of SIRT1\/Nrf2 and amelioration ER Stress"],"prefix":"10.1007","volume":"33","author":[{"given":"Magda E.","family":"El-Sayad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally E.","family":"Abu-Risha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1355-5877","authenticated-orcid":false,"given":"Sarah S.","family":"El-sisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"2","key":"1970_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph16020168","volume":"16","author":"WY Abdelzaher","year":"2023","unstructured":"Abdelzaher WY et al (2023) Empagliflozin protects against haloperidol experimentally-induced ovarian toxicity. Pharmaceuticals 16(2):1\u201312. https:\/\/doi.org\/10.3390\/ph16020168","journal-title":"Pharmaceuticals"},{"key":"1970_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)49278-0","author":"RH Abu-Baih","year":"2024","unstructured":"Abu-Baih RH, Abu-Baih DH, Abdel-Hafez SMN, Fathy M (2024) Activation of SIRT1\/Nrf2\/HO-1 and Beclin-1\/AMPK\/mTOR autophagy pathways by eprosartan ameliorates testicular dysfunction induced by testicular torsion in rats. Sci Rep. https:\/\/doi.org\/10.1016\/S0022-5347(17)49278-0","journal-title":"Sci Rep"},{"issue":"7","key":"1970_CR3","doi-asserted-by":"publisher","first-page":"103191","DOI":"10.1016\/j.arabjc.2021.103191","volume":"14","author":"MM Algandaby","year":"2021","unstructured":"Algandaby MM (2021) Quercetin attenuates cisplatin-induced ovarian toxicity in rats: emphasis on anti-oxidant, anti-inflammatory and anti-apoptotic activities. Arab J Chem 14(7):103191. https:\/\/doi.org\/10.1016\/j.arabjc.2021.103191","journal-title":"Arab J Chem"},{"key":"1970_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122769","author":"A Al-Shahat","year":"2022","unstructured":"Al-Shahat A et al (2022) Melatonin mitigates cisplatin-induced ovarian dysfunction via altering steroidogenesis, inflammation, apoptosis, oxidative stress, and PTEN\/PI3K\/Akt\/mTOR\/AMPK signaling pathway in female rats. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14122769","journal-title":"Pharmaceutics"},{"issue":"1","key":"1970_CR5","doi-asserted-by":"publisher","first-page":"327240","DOI":"10.1155\/2013\/327240","volume":"2013","author":"D Altuner","year":"2013","unstructured":"Altuner D, Gulaboglu M, Yapca OE, Cetin N (2013) The effect of Mirtazapine on Cisplatin-induced oxidative damage and infertility in rat ovaries. Sci World J 2013(1):327240. https:\/\/doi.org\/10.1155\/2013\/327240","journal-title":"Sci World J"},{"key":"1970_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063107","author":"T Androutsakos","year":"2022","unstructured":"Androutsakos T et al (2022) SGLT-2 inhibitors in NAFLD: expanding their role beyond diabetes and cardioprotection? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23063107","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1970_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/01913123.2019.1711479","volume":"44","author":"AD An\u011f\u0131n","year":"2020","unstructured":"An\u011f\u0131n AD et al (2020) Investigation of the preventive effects of dehydroepiandrosterone (DHEA) and caffeic acid phenethyl ester (CAPE) on cisplatin-induced ovarian damage in rats. Ultrastruct Pathol 44(1):71\u201380. https:\/\/doi.org\/10.1080\/01913123.2019.1711479","journal-title":"Ultrastruct Pathol"},{"issue":"2","key":"1970_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/jog.15119","volume":"48","author":"E Ayazoglu Demir","year":"2022","unstructured":"Ayazoglu Demir E, Mentese A, Kucuk H, Turkmen Alemdar N, Demir S (2022) P-coumaric acid alleviates cisplatin-induced ovarian toxicity in rats. J Obstet Gynaecol Res 48(2):411\u2013419. https:\/\/doi.org\/10.1111\/jog.15119","journal-title":"J Obstet Gynaecol Res"},{"issue":"20","key":"1970_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21207792","volume":"21","author":"HW Cho","year":"2020","unstructured":"Cho HW et al (2020) Advances in the treatment and prevention of chemotherapy-induced ovarian toxicity. Int J Mol Sci 21(20):1\u201320. https:\/\/doi.org\/10.3390\/ijms21207792","journal-title":"Int J Mol Sci"},{"key":"1970_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Bernard Tchounwou P (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1970_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0278-6915(00)00117-4","volume":"39","author":"P Debersac","year":"2001","unstructured":"Debersac P, Vernevaut MF, Amiot MJ, Suschetet M, Siess MH (2001) Effects of a water-soluble extract of rosemary and its purified component rosmarinic acid on xenobiotic-metabolizing enzymes in rat liver. Food Chem Toxicol 39(2):109\u2013117. https:\/\/doi.org\/10.1016\/S0278-6915(00)00117-4","journal-title":"Food Chem Toxicol"},{"key":"1970_CR12","doi-asserted-by":"publisher","first-page":"127356","DOI":"10.1016\/j.jtemb.2023.127356","volume":"82","author":"EA Demir","year":"2024","unstructured":"Demir EA (2024) Syringic acid alleviates cisplatin-induced ovarian injury through modulating endoplasmic reticulum stress, inflammation and Nrf2 pathway. J Trace Elem Med Biol 82:127356. https:\/\/doi.org\/10.1016\/j.jtemb.2023.127356","journal-title":"J Trace Elem Med Biol"},{"issue":"4","key":"1970_CR13","doi-asserted-by":"publisher","first-page":"100824","DOI":"10.1016\/j.repbio.2023.100824","volume":"23","author":"EA Demir","year":"2023","unstructured":"Demir EA, Mentese A, Yilmaz ZS, Alemdar NT, Demir S, Aliyazicioglu Y (2023) Evaluation of the therapeutic effects of arbutin on cisplatin-induced ovarian toxicity in rats through endoplasmic reticulum stress and Nrf2 pathway. Reprod Biol 23(4):100824. https:\/\/doi.org\/10.1016\/j.repbio.2023.100824","journal-title":"Reprod Biol"},{"issue":"1","key":"1970_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.9758\/cpn.2023.21.1.171","volume":"21","author":"E Dirican","year":"2023","unstructured":"Dirican E, \u00d6zcan H, Uzun\u00e7akmak SK, Tak\u0131m U (2023) Evaluation expression of the Caspase-3 and Caspase-9 apoptotic genes in schizophrenia patients. Clin Psychopharmacol Neurosci 21(1):171. https:\/\/doi.org\/10.9758\/cpn.2023.21.1.171","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"1970_CR15","doi-asserted-by":"publisher","first-page":"152134","DOI":"10.1016\/j.acthis.2024.152134","volume":"126","author":"H Hu","year":"2024","unstructured":"Hu H et al (2024) SIRT1 regulates endoplasmic reticulum stress-related organ damage. Acta Histochem 126(1):152134. https:\/\/doi.org\/10.1016\/j.acthis.2024.152134","journal-title":"Acta Histochem"},{"key":"1970_CR16","doi-asserted-by":"publisher","first-page":"109402","DOI":"10.1016\/j.cbi.2021.109402","volume":"338","author":"MA Ibrahim","year":"2021","unstructured":"Ibrahim MA et al (2021) Resveratrol protects against cisplatin-induced ovarian and uterine toxicity in female rats by attenuating oxidative stress, inflammation and apoptosis. Chem Biol Interact 338:109402. https:\/\/doi.org\/10.1016\/j.cbi.2021.109402","journal-title":"Chem Biol Interact"},{"key":"1970_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1273966","author":"A Iwase","year":"2023","unstructured":"Iwase A et al (2023) Anti-M\u00fcllerian hormone beyond an ovarian reserve marker: the relationship with the physiology and pathology in the life-long follicle development. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/fendo.2023.1273966","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1970_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3906\/sag-1803-196","volume":"50","author":"S Karaka\u015f","year":"2020","unstructured":"Karaka\u015f S et al (2020) Effect of metformin and detorsion treatment on serum anti-M\u00fcllerian hormonelevels and ovarian histopathology in a rat ovarian torsion model. Turkish J Med Sci 50(2):455\u2013463. https:\/\/doi.org\/10.3906\/sag-1803-196","journal-title":"Turkish J Med Sci"},{"key":"1970_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.biopha.2018.03.119","volume":"102","author":"E kaygusuzoglu","year":"2018","unstructured":"kaygusuzoglu E et al (2018) Zingerone ameliorates cisplatin-induced ovarian and uterine toxicity via suppression of sex hormone imbalances, oxidative stress, inflammation and apoptosis in female wistar rats. Biomed Pharmacother 102:517\u2013530. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.119","journal-title":"Biomed Pharmacother"},{"issue":"28","key":"1970_CR20","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.3748\/wjg.v25.i28.3664","volume":"25","author":"A Kontana","year":"2019","unstructured":"Kontana A, Tziomalos K (2019) Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease. World J Gastroenterol 25(28):3664\u20133668. https:\/\/doi.org\/10.3748\/wjg.v25.i28.3664","journal-title":"World J Gastroenterol"},{"key":"1970_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.150620","author":"J Lee","year":"2024","unstructured":"Lee J et al (2024) Sodium-glucose cotransporter 2 inhibitors ameliorate ER stress-induced pro-inflammatory cytokine expression by inhibiting CD36 in NAFLD progression in vitro. Biochem Biophys Res Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150620","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1970_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3802\/jgo.2013.24.2.177","volume":"24","author":"X Li","year":"2013","unstructured":"Li X et al (2013) The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats. J Gynecol Oncol 24(2):177. https:\/\/doi.org\/10.3802\/jgo.2013.24.2.177","journal-title":"J Gynecol Oncol"},{"key":"1970_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.622153","author":"T Li","year":"2021","unstructured":"Li T et al (2021) Empagliflozin alleviates hepatic steatosis by activating the AMPK-TET2-autophagy pathway in vivo and in vitro. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.622153","journal-title":"Front Pharmacol"},{"key":"1970_CR24","doi-asserted-by":"publisher","first-page":"111552","DOI":"10.1016\/j.biopha.2021.111552","volume":"139","author":"P Liu","year":"2021","unstructured":"Liu P et al (2021) Hesperetin modulates the Sirt1\/Nrf2 signaling pathway in counteracting myocardial ischemia through suppression of oxidative stress, inflammation, and apoptosis. Biomed Pharmacother 139:111552. https:\/\/doi.org\/10.1016\/j.biopha.2021.111552","journal-title":"Biomed Pharmacother"},{"issue":"31","key":"1970_CR25","doi-asserted-by":"publisher","first-page":"e2303448120","DOI":"10.1073\/pnas.2303448120","volume":"120","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu G, Ha DP, Wang J, Xiong M, Lee AS (2023) ER chaperone GRP78\/BiP translocates to the nucleus under stress and acts as a transcriptional regulator. Proc Natl Acad Sci U S A 120(31):e2303448120. https:\/\/doi.org\/10.1073\/pnas.2303448120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1970_CR26","doi-asserted-by":"publisher","first-page":"257126","DOI":"10.3389\/fnagi.2017.00366","volume":"9","author":"H Luo","year":"2017","unstructured":"Luo H et al (2017) Expression of Sirtuins in the retinal neurons of mice, rats, and humans. Front Aging Neurosci 9:257126. https:\/\/doi.org\/10.3389\/fnagi.2017.00366","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1970_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/dom.12183","volume":"16","author":"S Macha","year":"2014","unstructured":"Macha S et al (2014) Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment. Diabetes Obes Metab 16(2):118\u2013123. https:\/\/doi.org\/10.1111\/dom.12183","journal-title":"Diabetes Obes Metab"},{"key":"1970_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2147\/OPTH.S287747","volume":"15","author":"RP Maurya","year":"2021","unstructured":"Maurya RP et al (2021) Serum malondialdehyde as a biomarker of oxidative stress in patients with primary ocular carcinoma: impact on response to chemotherapy. Clin Ophthalmol 15:871\u2013879. https:\/\/doi.org\/10.2147\/OPTH.S287747","journal-title":"Clin Ophthalmol"},{"key":"1970_CR29","doi-asserted-by":"publisher","first-page":"113995","DOI":"10.1016\/j.fct.2023.113995","volume":"179","author":"AH Moslehi","year":"2023","unstructured":"Moslehi AH, Hoseinpour F, Saber A, Akhavan Taheri M, Hashemian AH (2023) Fertility-enhancing effects of inositol & vitamin C on cisplatin induced ovarian and uterine toxicity in rats via suppressing oxidative stress and apoptosis. Food Chem Toxicol 179:113995. https:\/\/doi.org\/10.1016\/j.fct.2023.113995","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"1970_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.5603\/EP.a2023.0039","volume":"74","author":"D Nabrdalik-Le\u015bniak","year":"2023","unstructured":"Nabrdalik-Le\u015bniak D et al (2023) The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes. Endokrynol Pol 74(4):349\u2013362. https:\/\/doi.org\/10.5603\/EP.a2023.0039","journal-title":"Endokrynol Pol"},{"issue":"2","key":"1970_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22020818","volume":"22","author":"N Nasiri-Ansari","year":"2021","unstructured":"Nasiri-Ansari N et al (2021) Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE(-\/-) mice by activating autophagy and reducing ER stress and apoptosis. Int J Mol Sci 22(2):1\u201321. https:\/\/doi.org\/10.3390\/ijms22020818","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1970_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/molehr\/gaz020","volume":"25","author":"QN Nguyen","year":"2019","unstructured":"Nguyen QN, Zerafa N, Liew SH, Findlay JK, Hickey M, Hutt KJ (2019) Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes. Mol Hum Reprod 25(8):433\u2013444. https:\/\/doi.org\/10.1093\/molehr\/gaz020","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"1970_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pharmthera.2012.07.003","volume":"136","author":"SM Sancho-Mart\u00ednez","year":"2012","unstructured":"Sancho-Mart\u00ednez SM, Prieto-Garc\u00eda L, Prieto M, L\u00f3pez-Novoa JM, L\u00f3pez-Hern\u00e1ndez FJ (2012) Subcellular targets of cisplatin cytotoxicity: an integrated view. Pharmacol Ther 136(1):35\u201355. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.07.003","journal-title":"Pharmacol Ther"},{"key":"1970_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Ahmedin J, Siegel RL (2024) Cancer statistics 2024. CA Cancer J Clin 74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"1970_CR35","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3724\/abbs.2023285","volume":"56","author":"J Tang","year":"2024","unstructured":"Tang J et al (2024) Agrimol B alleviates cisplatin-induced acute kidney injury by activating the Sirt1\/Nrf2 signaling pathway in mice. Acta Biochim Biophys Sin (Shanghai) 56(4):551\u2013563. https:\/\/doi.org\/10.3724\/abbs.2023285","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"2","key":"1970_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.5114\/aoms.2019.87540","volume":"19","author":"M Tas","year":"2019","unstructured":"Tas M, Oner G, Ulug P, Yavuz A, Ozcelik B (2019) Evaluation of protective effects of GnRH agonist or antagonist on ovarian reserve with anti-M\u00fcllerian hormone and histological analysis in a rat model using cisplatin. Arch Med Sci 19(2):448. https:\/\/doi.org\/10.5114\/aoms.2019.87540","journal-title":"Arch Med Sci"},{"key":"1970_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s11658-019-0158-9","volume":"24","author":"Z Ren","year":"2019","unstructured":"Ren Z, He H, Zuo Z, Xu Z, Wei Z,Deng J (2019) The role of different SIRT1-mediated signaling pathways in toxic injury. Cell Mol Biol Lett 24:36. Published 30 May 2019. Accessed: january 2, 2024","journal-title":"Cell Mol Biol Lett"},{"issue":"6","key":"1970_CR38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/1440-1681.13470","volume":"48","author":"G Tian","year":"2021","unstructured":"Tian G, Yu Y, Deng H, Yang L, Shi X, Yu B (2021) Empagliflozin alleviates ethanol-induced cardiomyocyte injury through inhibition of mitochondrial apoptosis via a SIRT1\/PTEN\/Akt pathway. Clin Exp Pharmacol Physiol 48(6):837\u2013845. https:\/\/doi.org\/10.1111\/1440-1681.13470","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"1970_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox10081166","volume":"10","author":"KF Tsai","year":"2021","unstructured":"Tsai KF et al (2021) Emergence of sglt2 inhibitors as powerful antioxidants in human diseases. Antioxidants 10(8):1\u201326. https:\/\/doi.org\/10.3390\/antiox10081166","journal-title":"Antioxidants"},{"issue":"4","key":"1970_CR40","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00404-021-06292-4","volume":"305","author":"EO Tutar","year":"2022","unstructured":"Tutar EO et al (2022) Dose-dependent effects of ghrelin and aberrant anti-Mullerian hormone levels in the prevention of ovarian damage caused by cisplatin in Wistar-albino rats. Arch Gynecol Obstet 305(4):1003\u20131009. https:\/\/doi.org\/10.1007\/s00404-021-06292-4","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"1970_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.reprotox.2009.08.003","volume":"28","author":"J Yeh","year":"2009","unstructured":"Yeh J, Kim BS, Liang YJ, Peresie J (2009) Gonadotropin stimulation as a challenge to calibrate cisplatin induced ovarian damage in the female rat. Reprod Toxicol 28(4):556\u2013562. https:\/\/doi.org\/10.1016\/j.reprotox.2009.08.003","journal-title":"Reprod Toxicol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01970-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01970-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01970-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:02:36Z","timestamp":1763420556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01970-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01970-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}